Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideZBHZimmer Biomet
FinDog View：Neutral
| Metric | AMGN | ZBH |
|---|
| Close | 376.35 | 96.78 |
| Market Cap | $203B | $18.4B |
| 1M | −10.26% | −1.45% |
| P/E (TTM) | 23.3 | 22.1 |
| Forward P/E | 16.9 | 10.8 |
| P/E 5-Yr Percentile | 27 | 25 |
| P/S | 5.4 | 2.1 |
| P/B | 17.4 | 1.4 |
| Dividend Yield | 3.21% | 1.04% |
| Latest Quarter Revenue | $10.1B | $2.2B |
| Revenue YoY | +9.5% | +4.8% |
| Gross Margin | 72.0% | 70.8% |
| Latest Quarter EPS | 4.37 | 1.03 |
| Avg Post-Earnings Move | ±5.2% | ±2.1% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.60% | 5.11% |
| 90-Day Net Insider Buying | −$4.1M | −$0.82M |
AMGN · Revenue, Last 8 Quarters ($B)
ZBH · Revenue, Last 8 Quarters ($B)
